The incidence of colonic natural killer cells, large granular lymphocytes and mast cells in inflammatory bowel disease
- PMID: 7502796
The incidence of colonic natural killer cells, large granular lymphocytes and mast cells in inflammatory bowel disease
Similar articles
-
Interferon alpha-2A (roferon) as a treatment of inflammatory bowel disease in children and adolescents.Adv Exp Med Biol. 1995;371B:1323-6. Adv Exp Med Biol. 1995. PMID: 7502809 No abstract available.
-
P-ANCA as a differential diagnostic marker in inflammatory bowel disease.Adv Exp Med Biol. 1995;371B:1313-6. Adv Exp Med Biol. 1995. PMID: 7502807 No abstract available.
-
Distribution and density of TNF immunoreactivity in chronic inflammatory bowel disease.Adv Exp Med Biol. 1995;371B:1327-30. Adv Exp Med Biol. 1995. PMID: 7502810 No abstract available.
-
Immunological aspects of inflammatory bowel disease.Endoscopy. 1992 Aug;24(6):568-77. doi: 10.1055/s-2007-1010547. Endoscopy. 1992. PMID: 1396367 Review. No abstract available.
-
Living on the edge: immune cells and immunopathology in the intestinal mucosa.Semin Immunopathol. 2009 Jul;31(2):143-4. doi: 10.1007/s00281-009-0162-7. Semin Immunopathol. 2009. PMID: 19495756 Review. No abstract available.
Cited by
-
Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines.Gut. 1998 Feb;42(2):208-13. doi: 10.1136/gut.42.2.208. Gut. 1998. PMID: 9536945 Free PMC article.